Pharmaids Pharmaceuticals has acquired 9.35% of f partnership interest totaling 50.60% out of the said proposed investment of 51% in Anugraha Chemicals (partnership firm) till date. Anugraha Chemicals is engaged in contract manufacturing and manufacturing of APIs, Intermediates and Fine Chemicals. The aggregate proposed investment is Rs 5.14 crore for 51% partnership interest stake in the firm in multiple tranches.Powered by Capital Market - Live News

Net Loss of Pharmaids Pharmaceuticals reported to Rs 1.63 crore in the quarter ended December 2023 as against net loss of Rs 0.71 crore during the previous quarter ended December 2022. Sales reported to Rs 0.02 crore in the quarter ended December 2023. There were no Sales reported during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.020 0 OPM %-6500.000 - PBDT-2.20-0.70 -214 PBT-2.21-0.71 -211 NP-1.63-0.71 -130 Powered by Capital Market - Live News

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Pharmaids Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 January 2024 .Powered by Capital Market - Live News

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 January 2024.Powered by Capital Market - Live News